Manatt Health August 31, 2021
The Biden Administration this month significantly relaxed several compliance obligations related to price transparency and surprise billing that have been of intense concern to the health care industry—and had already prompted litigation. While these changes, which delay implementation of statutory requirements either indefinitely or for a period of at least six months, give health plans, health care providers and pharmaceutical manufacturers more flexibility, the new federal surprise billing and price transparency laws remain poised to reshape financial management of the health care industry.
The Health and Human Services (HHS), Labor, and Treasury Departments released guidance on August 20 that delays certain compliance deadlines in the No Surprises Act (which Congress enacted as part of the Consolidated Appropriations Act, 2021, in...